819-P: A Novel Premix Insulin GZR101 for Diabetes Management

内科学 内分泌学 胰岛素 脱胶胰岛素 化学 血糖性 糖尿病 人血清白蛋白 脂肪生成 体内 基础(医学) 基础胰岛素 医学 2型糖尿病 生物 脂肪组织 生物化学 生物技术
作者
Wei Chen,Wancai Xing,Yining Zhang,Anshun He,JING GAO,QIMIN SHI,Fangkai Xue,YONGCHUN WANG,Jun Zhang,DONGLI YU,Cheng Cui,TIAN XIE,ZHONGRU GAN
出处
期刊:Diabetes [American Diabetes Association]
卷期号:73 (Supplement_1)
标识
DOI:10.2337/db24-819-p
摘要

Introduction: Inadequate glycemic control in patients with premix insulin regimen is often due to the short half-life and pronounced peak-to-trough ratio of basal insulin. This necessitates the development of a premix insulin containing basal insulins with an extended half-life and steady pharmacokinetic (PK) profile. Objective: This study evaluated and characterized GZR33, an ultra-long half-life basal insulin, and GZR101 which is composed by GZR33 and insulin aspart. Methods: The binding affinity of GZR33 to the human insulin receptor (hIR) was analyzed in vitro using surface plasmon resonance. IR activation was examined in CHO cells in the presence and absence of human serum albumin (HSA). Adipogenesis was measured in 3T3L1 MBX cells. Potency was tested in vivo in streptozotocin-induced T1DM rats and db/db T2DM mice, using insulin degludec (iDeg) and iDegAsp as controls. PK studies were assessed in Sprague-Dawley rats. Results: GZR33 was constructed by linking a C22 fatty diacid side chain to desB30 human insulin via a 6×OEG linker. GZR33 exhibited strong hIRA and hIRB binding (dissociation constants: 2.86E-6 M and 1.28E-6 M). It activated IRA and IRB with EC50 of 370.13 ± 94.86 nM and 477.48 ± 64.28 nM, respectively, in 0.5% HSA, and induced adipogenesis with an EC50 of 2.45 ± 0.81 nM. PK studies showed a dose-dependent increase in maximum concentration and exposure, with a T½ of 5.45 h for GZR33 (2.3 h for iDeg). In T1DM rats and T2DM mice, GZR33 outperformed iDeg in reducing HbA1c and FBG, demonstrating a potency at least three-fold higher than iDeg. Additionally, GZR101's glucose-lowering effect was proportional to the GZR33 dosage in diabetic models. Conclusion: Traditional basal insulins display a 24-hour glucose-lowering effect with noticeable peaks, leading to fluctuating blood glucose in patients. However, a basal insulin with over 3-day longevity and once-daily dosing, like GZR33, can achieve a nearly peak-less PK profile at steady-state. Consequently, GZR101 emerges as a promising once-daily premix insulin candidate. Disclosure W. Chen: None. W. Xing: None. Y. Zhang: None. A. He: None. J. Gao: None. Q. Shi: None. F. Xue: None. Y. Wang: None. J. Zhang: None. D. Yu: None. C. Cui: None. T. Xie: None. Z. Gan: None.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
xie发布了新的文献求助10
刚刚
AJIJDKDN完成签到,获得积分10
刚刚
1秒前
在水一方应助老实皮卡丘采纳,获得10
1秒前
张伟完成签到,获得积分10
2秒前
烟花应助luu采纳,获得10
2秒前
2秒前
spring完成签到,获得积分10
3秒前
MJ发布了新的文献求助20
3秒前
MT完成签到 ,获得积分10
3秒前
调研昵称发布了新的文献求助30
4秒前
4秒前
4秒前
善学以致用应助Tao采纳,获得10
5秒前
张伟发布了新的文献求助10
5秒前
GWZZ完成签到,获得积分10
5秒前
5秒前
爆米花应助小何采纳,获得10
5秒前
7秒前
xie完成签到,获得积分10
7秒前
7秒前
8秒前
调研昵称发布了新的文献求助30
9秒前
10秒前
复杂薯片发布了新的文献求助10
10秒前
11秒前
所所应助科研通管家采纳,获得10
11秒前
iNk应助科研通管家采纳,获得10
11秒前
宵荷发布了新的文献求助10
11秒前
bkagyin应助科研通管家采纳,获得10
11秒前
Singularity应助科研通管家采纳,获得10
12秒前
小二郎应助科研通管家采纳,获得10
12秒前
折花浅笑完成签到,获得积分10
12秒前
丘比特应助科研通管家采纳,获得10
12秒前
不配.应助科研通管家采纳,获得10
12秒前
12秒前
星辰大海应助科研通管家采纳,获得10
12秒前
共享精神应助科研通管家采纳,获得30
12秒前
12秒前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
Foreign Policy of the French Second Empire: A Bibliography 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
XAFS for Everyone 500
Classics in Total Synthesis IV 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3144274
求助须知:如何正确求助?哪些是违规求助? 2795879
关于积分的说明 7816861
捐赠科研通 2451946
什么是DOI,文献DOI怎么找? 1304774
科研通“疑难数据库(出版商)”最低求助积分说明 627291
版权声明 601419